Delivery Order SPE2DB22D2009-SPE2DB25FM0GG
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ibuprofen 800 mg tablets in quantities of 500 units. This firm fixed-price delivery order, valued at $5,354.10, is due for completion by July 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical...
- The Defense Department's Medical Supply Chain awarded a $4,767.26 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the procurement of Ibuprofen 800 mg tablets (500-count units). This is a firm fixed price, competitively awarded contract with performance to be completed by July 21, 2025, and will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award. This delivery order is issued under...
- This $1,741.12 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,331,538 units of 800mg ibuprofen tablets by May 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp for $17,656.76 to supply 4,565,882 units of ibuprofen 100mg tablets. The contract is a firm-fixed price agreement with an ultimate completion date of October 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medical commodities to support military treatment facilities and programs. This delivery order is part of a larger...
- This federal contract award is for the delivery of 4,564,151 units of 600mg ibuprofen tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The $1,461.60 fixed-price delivery order was awarded on April 3, 2024 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract has an ultimate completion date of April 30, 2024 and does not include any set-aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,347.60, is for the delivery of Ibuprofen 800mg tablets and has an ultimate completion date of December 12, 2023. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $4,162.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 count bottles of 800 mg ibuprofen tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order period of performance is from August 11-14, 2023. DLA utilizes such delivery orders to fulfill requirements under various pharmaceutical supply contracts, ensuring service members and other beneficiaries have access to...
- The Defense Logistics Agency awarded a $1,627 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 count bottles of 800mg ibuprofen tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is September 8-11, 2023. This delivery order was issued under the DLA's Pharmaceutical Prime Vendor contract, which streamlines the Defense Department's procurement and distribution of prescription drugs and other medical...
- The Defense Logistics Agency awarded a $3,814.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 ibuprofen 800 mg tablets. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required between September 9-11, 2023. No subcontractors or set...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $355.12 to supply 4561836476 IBUPROFEN 800 MG TABLET 30S. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical products from its Conshohocken, Pennsylvania facility by August 17, 2023 in support of the Defense Logistics Agency's medical supply chain responsibilities. No subcontractors or set aside designations were indicated. The delivery order was...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0GGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Ibuprofen 800 mg tablets in quantities of 500 units under a firm fixed-price contract valued at $2,958.36. This non-set-aside delivery order is set for completion by July 17, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through AmerisourceBergen's established federal supply relationships. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems and the Defense Health Agency. The company's competitively awarded contracts with DLA demonstrate its capability to fulfill federal medical supply requirements across multiple therapeutic domains on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/16/25 |